SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-101289
Filing Date
2024-04-19
Accepted
2024-04-18 21:45:31
Documents
19
Period of Report
2024-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d826712d8k.htm   iXBRL 8-K 49594
2 EX-4.1 d826712dex41.htm EX-4.1 83355
3 EX-10.1 d826712dex101.htm EX-10.1 247508
4 EX-10.2 d826712dex102.htm EX-10.2 79369
5 EX-10.3 d826712dex103.htm EX-10.3 18301
6 EX-10.4 d826712dex104.htm EX-10.4 14214
7 EX-99.1 d826712dex991.htm EX-99.1 12081
  Complete submission text file 0001193125-24-101289.txt   755741

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA bntc-20240417.xsd EX-101.SCH 2886
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20240417_lab.xml EX-101.LAB 17235
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20240417_pre.xml EX-101.PRE 10836
22 EXTRACTED XBRL INSTANCE DOCUMENT d826712d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 24855465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)